talksle logo

Dedicated to increasing awareness about
systemic lupus erythematosus (SLE), disease activity and related organ damage

CLINICAL PRESENTATION
AND DIAGNOSIS OF SLE

Patients with SLE may present with a variety of symptoms. The diverse clinical manifestations of SLE are the result of inflammation in affected organ systems.1

As a result, diagnosing SLE can be challenging. At times, diagnosing a patient can be time-consuming, requiring a high level of communication between the patient and the physician. Both parties must be thoroughly engaged in the process to ensure the best possible outcome — in the short term and over time.2

It is important to note that there can be a significant gap between what patients experience and what they are willing to share with their physicians.

Learn more about the intricacies and subtleties of diagnosing SLE.

In one survey, 52% of patients with SLE reported they minimize their symptoms when speaking with their physicians.3,*

*Data from the 2011 National Burden of Lupus survey was funded and developed by GSK. This survey included 957 people in the lupus community — 502 people who reported being diagnosed with SLE, 204 supporters (family members or friends) of people with lupus and 251 rheumatologists.

SYSTEMIC LUPUS ERYTHEMATOSUS
(SLE): FOCUS ON
ORGAN DAMAGE

A flipchart featuring an overview of SLE and the damage it may cause
to
organ systems.

View Now (PDF)

CLINICAL IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY ON LONG-TERM ORGAN DAMAGE

R. Elaine Lambert, MD,
in a question and answer
format.

This promotional program was developed in conjunction with and sponsored by GSK, based on an interview with R. Elaine Lambert, MD.

Dr. Lambert received a fee for participation in this program.

View Now (PDF)

What Next?

The diverse clinical manifestations of SLE are the result of inflammation in affected organ systems.1

Learn more now

References:
1. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum. 1999;42(9):1785-1796. http://www.ncbi.nlm.nih.gov/pubmed/10513791. Accessed February 14, 2017. 2. van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis. 2014;73(6):958-967. http://dx.doi.org/10.1136/annrheumdis-2013-205139. Accessed February 14, 2017. 3. Lupus Foundation of America. UNVEIL Survey Fact Sheet. http://www.lupus.org/page/-/files/pdf/Unveil%20Survey
%20Fact%20Sheet.pdf. Accessed February 14, 2017.